NetworkNewsBreaks

WednesdayMay 13, 2026 11:55 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Permanent Ukraine Operations to Accelerate Overwatch Adoption

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced plans to establish permanent operations in Ukraine through a wholly owned subsidiary to accelerate adoption of its Overwatch autonomous mission software across the country’s defense drone market. The expansion includes building an in-country commercial and technical team, opening a physical office, and appointing Greg Daly as chief strategy and mission integration officer to lead execution, as the company works to convert growing engagement with Ukrainian drone manufacturers and operators into recurring software sales while expanding…

Continue Reading

WednesdayMay 13, 2026 11:51 am

NetworkNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Advances São Sepé Rare Earth Project With Drill Program Underway 

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.  Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) provided an update on its São Sepé rare earth project in Brazil, where historical surface sampling identified three priority exploration targets prospective for ionic adsorption clay-hosted rare earth mineralization. The company has commenced an approximately 500-meter auger drill program, expected to run four to six weeks, to follow up on elevated rare earth oxide values and test the lateral continuity of potential mineralization across the Sara, Erica and Maya target areas. To view the full press release, visit https://nnw.fm/hX5Fx About Canamera Energy Metals Corp. Canamera Energy Metals Corp. is a rare earth and critical metals exploration company…

Continue Reading

WednesdayMay 13, 2026 11:40 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Software-Driven Drone Autonomy 

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising.  SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) was featured in AINewsWire editorial coverage examining the accelerating shift toward software-defined autonomous warfare, with the company highlighted for its Overwatch platform designed to provide GPS-denied navigation and precision targeting for low-cost drones operating in contested environments. The editorial emphasizes that while inexpensive drone hardware has become widely available and increasingly central to modern conflict, particularly in active war zones, the software intelligence required for autonomous operation under electronic warfare conditions remains a critical gap SPARC AI is seeking to address. The coverage also positions SPARC AI alongside other defense and…

Continue Reading

WednesdayMay 13, 2026 11:31 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Announces First Patient Dosed in Phase 1b Trial of Sapu003 

Oncotelic Therapeutics (OTCQB: OTLC), alongside Sapu Nano, announced that the first patient has been dosed in the Phase 1b clinical trial evaluating Sapu003, an investigational intravenous Deciparticle(TM) formulation of everolimus for patients with advanced mTOR-sensitive solid tumors. The open-label, dose-escalation study is designed to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity across patient cohorts including HR-positive/HER2-negative breast cancer and multiple additional tumor types, with Sapu003 developed as a weekly IV formulation intended to address limitations associated with oral everolimus delivery, including variable absorption and dose-limiting toxicity. To view the full press release, visit https://nnw.fm/XXnpF About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development…

Continue Reading

WednesdayMay 13, 2026 9:35 am

NetworkNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) was featured in BioMedWire editorial coverage examining the rapid growth of the GLP-1 market, with the company highlighted for its subsidiary GlucaPharm Inc. and its development of GEP-44, a patented triple agonist peptide licensed from Syracuse University. The editorial notes that GEP-44 is designed to target GLP-1 and peptide YY receptors Y1 and Y2, positioning SureNano as an emerging microcap participant seeking to address limitations of first-generation GLP-1 therapies, including efficacy, tolerability and delivery flexibility. The coverage also…

Continue Reading

WednesdayMay 13, 2026 9:20 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery

Oncotelic Therapeutics (OTCQB: OTLC) was featured in BioMedWire editorial coverage examining the growing urgency around effective central nervous system drug delivery, with the company highlighted for its proprietary intranasal nose-to-brain delivery platform designed to bypass the blood-brain barrier and deliver therapeutics directly to the brain. The editorial points to rising global Alzheimer’s cases and increased biodefense focus as major catalysts driving demand for faster, more targeted CNS delivery technologies, positioning Oncotelic’s platform-based approach as part of a broader shift toward delivery innovation as a critical determinant of therapeutic success. The coverage also places Oncotelic alongside major biopharma and advanced therapeutics…

Continue Reading

WednesdayMay 13, 2026 9:10 am

NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the limitations of conventional detection tools such as breathalyzers, blood draws and urine testing, noting MindBio’s focus on scalable, real-time assessment across multiple substances for potential applications in workplace safety, law enforcement, healthcare and public health.…

Continue Reading

TuesdayMay 12, 2026 12:15 pm

NetworkNewsBreaks – Titan Partners Group LLC Expands Equity Research Division with Three Senior Analyst Appointments

Titan Partners, a division of American Capital Partners, has appointed Scott Buck, Kyle Bauser, Ph.D., and Adam Kelsey, CFA, to significantly expand its equity research platform across technology, healthcare, and energy, power and infrastructure. The three analysts bring more than 40 years of combined middle-market equity research experience, strengthening Titan’s sector-focused research capabilities as the firm continues to build its investment banking platform focused on underfollowed small- and mid-cap public companies. To view the full press release, visit https://nnw.fm/6KxBz About Titan Partners Titan Partners, a division of American Capital Partners, is a boutique investment bank specializing in tailored solutions for…

Continue Reading

TuesdayMay 12, 2026 12:01 pm

NetworkNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Commences 2026 Drilling at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.  Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) has commenced drilling on the first hole of its 2026 exploration program at the Murdock Mountain Project, with initial deep drill hole MM26-7 designed as a 100-meter step-back from last fall’s MM25-1 to further evaluate the thickness, continuity and phosphate grade characteristics of the Meade Peak Upper Phosphatic Zone at depth. The company said minor technical drilling issues were identified and are being addressed by contractor FTE Drilling, with operations expected to resume shortly and no material delays anticipated. To view the full press release, visit https://nnw.fm/0r6cd Nevada Organic…

Continue Reading

TuesdayMay 12, 2026 11:51 am

NetworkNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation 

This article has been disseminated on behalf of SureNano Science Ltd.  and may include paid advertising.  SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its placement in a BioMedWire editorial examining the evolution of GLP-1 therapies and emerging innovation in obesity and metabolic disease treatment. The editorial highlights SureNano’s subsidiary GlucaPharm Inc. and its GEP-44 program, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in the rapidly expanding GLP-1 market, as demand continues to grow for next-generation therapies targeting obesity, type 2 diabetes and related chronic conditions. To view the full press release, visit https://nnw.fm/L3XpF About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing, and advancing innovative pharmaceutical…

Continue Reading